[Meropenem: microbiologic perspective]

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Meropenem is a semi-synthetic carbapenem antibiotic derived from thienamycin.
• It possesses a beta-methyl group conferring stability against renal dehydropeptidase 1 (DHP-1).
• Its unique stereochemical configuration enhances activity against gram-negative bacteria and reduces proconvulsive effects compared to imipenem/cilastatin.

Purpose of the Study:

• To detail the structural characteristics of meropenem.
• To elucidate its broad spectrum of activity and bactericidal power.
• To compare its efficacy against gram-negative and gram-positive bacteria relative to imipenem.

Main Methods:

• Structural analysis of meropenem.
• Assessment of meropenem's in vitro activity against a wide range of bacterial pathogens.
• Comparative analysis of meropenem and imipenem efficacy.

Main Results:

• Meropenem exhibits broad-spectrum activity against gram-positive aerobes, gram-negative bacteria (including Enterobacteriaceae and Pseudomonas aeruginosa), and anaerobes.
• It demonstrates superior activity against gram-negative pathogens like P. aeruginosa and Enterobacteriaceae compared to imipenem.
• Meropenem shows reduced activity against certain resistant strains, including Enterococcus faecium and methicillin-resistant Staphylococcus aureus.

Conclusions:

• Meropenem's structural features contribute to its stability, broad spectrum, and potent bactericidal activity.
• It is a highly effective antibiotic against a wide array of bacterial infections, particularly those caused by gram-negative organisms.
• Understanding resistance mechanisms, such as porin loss and carbapenemase production, is crucial for optimizing meropenem therapy.